Neutrophil (PMN) infiltration of the intestinal mucosa is a hallmark of gastrointestinal inflammation, with significant implications for host defense, injury and repair. However, phenotypic and mechanistic aspects of PMN recruitment in inflamed intestines have not been explored in vivo. Using novel epithelial/PMN fluorescence reporter mice, advanced intravital imaging and 3D reconstruction analysis, we mapped the microvasculature architecture across the intestinal layers and determined that in response to Salmonella/ endotoxin-induced inflammation, PMN transendothelial migration (TEM) was restricted to submucosal vessels. PMN TEM was not observed in villus or crypt vessels, proximal to the epithelium that underlies the intestinal lumen, and was partially dependent on (C-X-C motif) ligands 1 (CXCL1) and 2 (CXCL2) expression, which was found to be elevated in the submucosa layer. Restricted PMN extravasation at the submucosa and subsequent PMN interstitial migration may serve as a novel regulatory step of PMN effector function and recruitment to the luminal space in inflamed intestines.
INTRODUCTION
Polymorphonuclear leukocytes (PMNs) can function as a doubleedged sword promoting tissue injury and contributing to reestablishment of tissue homeostasis. 1, 2 As such, en masse PMN infiltration of mucosal surfaces including respiratory system, urinary and the gastrointestinal tracts is often associated with disruption of the critical barrier function and tissue injury. 3, 4 However, emerging evidence also convincingly implicates PMNs in the resolution of inflammation and wound repair. [5] [6] [7] PMN accumulation in the mucosa and luminal spaces is a hallmark of inflammatory bowel disease (IBD), a debilitating disorder affecting over a million individuals in the United States alone. 8 Although PMN presence in the intestinal tissue is generally viewed as detrimental and often correlates with disease symptoms, pro-repair functions of PMNs in the intestinal lumen are increasingly recognized. For example, PMN binding to and ligation of luminal receptors, such as intercellular adhesion molecule-1 (ICAM-1), has been suggested to promote epithelial proliferation and wound repair. 9 As with IBD, infection by common enteric pathogens, including Salmonella or Listeria, leading to symptomatic disease, elicits PMN recruitment and accumulation in the intestinal mucosa and the lumen. 10 Here too, while critical for host defense, excessive PMN tissue accumulation contributes to tissue dysfunction. 3 Given these important implications of PMN trafficking in the mucosa, there has been a long-standing interest in understanding the molecular basis and functional consequences of PMN interaction with the endothelium as they cross the vascular wall, and subsequently with the epithelial layer on their way to the intestinal lumen.
Many in vitro and in vivo models have been employed to study PMN transendothelial migration (TEM) and help define critical steps and key molecules involved in this process. However, only the use of emerging, advanced intravital imaging techniques allowed visualization and detailed examination of PMN interactions with endothelial cells (ECs) in various vascular beds and disease models. 11 Combined, these studies revealed that PMN activation, 12 endothelial adhesion molecule density, 13, 14 fluid shear forces 15 and geometry of the vascular bed itself 16 can significantly influence this process. Most PMN TEM in response to inflammation take place at post-capillary venules (15-40 μm in diameter). 17 At these sites, PMNs undergo sequential adhesive steps that include selectin-mediated rolling interactions and integrin-dependent PMN adhesion, followed by luminal locomotion (crawling) and terminating with TEM. 18 Interestingly, as was observed in lung circulation, the capillary bed can also support PMN TEM. 16 In fact, in response to distal pulmonary airspace inflammation, alveolar capillaries are the principal site of leukocyte extravasation. 19 Given the capillary size (2-15 μm in diameter), a simple physical trapping of PMNs rather than tethering interactions may be sufficient to initiate TEM. 19, 20 Importantly, across all vascular beds, including post-capillary venules and capillaries, the presence of chemotactic gradients and activation/upregulation of adhesive receptors is critical for PMN TEM. 21 Although PMN infiltration of the intestinal mucosa has long been known to be a prominent histological feature of intestinal inflammation, the fundamental mechanisms underpinning PMN TEM in the gut vasculature have largely gone unexplored. Furthermore, how the complex architecture and the multilayered structure of the intestines reflect on the PMN extravasation patterns is not clear. This work details the use of an advanced intravital imaging setup and a three-dimensional (3D) reconstruction analysis to map the microvasculature architecture across the layers of the small intestine and determine the patterns of PMN extravasation and recruitment to inflamed epithelium. As new information continues to emerge regarding the expanded life span of PMNs in tissue and the heterogeneity of PMN subsets and function, our understanding of the roles of PMNs in inflammation and pathology is rapidly evolving. As such, the specific activation state of the PMN and the immediate microenvironment and milieu of the intestinal regions likely plays a critical role in regulating TEM and the key effector functions of PMNs.
RESULTS

Pathogenic stimulus triggers PMN infiltration of the intestinal mucosa
In the setting of acute intestinal inflammation triggered by invading pathogens, such as Salmonella, PMNs are recruited to the intestinal mucosa and the epithelial layer. 10, 22 To examine this process in more detail, intestinal inflammation was induced by either oral gavage of Salmonella (10 8 in 100 µl by gavage, 24 h before sample collection) or by intraluminal administration of bacterial endotoxin (lipopolysaccharide (LPS), 100 µg/ml in 200 µl, 2 h before sample collection). In both inflammation models, PMN recruitment to intestinal epithelial cells (IECs) and the deeper lamina propria mucosa was quantified. In these experiments, intestines were harvested, cleaned and subjected to brief mechanical stress (in DTT/EDTA solution), which separates intestinal epithelium from the rest of the mucosa and the underlying muscular layer. [23] [24] [25] Both resulting fractions were processed to produce single-cell suspensions, which were then analyzed by flow cytometry to determine recruitment of PMNs. As expected, Salmonella treatment triggered robust PMN extravasation from the blood vessels and accumulation within the deeper layers of the lamina propria (LP) and the epithelium (Fig. 1a, b and representative flow micrograph, Fig. 1c ). Importantly, although to a slightly lesser degree, administration of LPS into the intestinal lumen (high dose of 100 µg) recapitulated a similarly robust but regulated PMN response (Fig. 1a, b and representative immunofluorescence images, Fig. 1d ). Inhibition of PMN interactions with the vascular wall by intravenous (i.v.) administration of functionblocking CD11b antibody (Ab) significantly decreased the number of tissue PMNs in both models of intestinal inflammation (Fig. 1a,  b ). These data suggest that PMN recruitment induced by both Salmonella and LPS follows well-established leukocyte-EC adhesion cascade. Because LPS produced a more consistent inflammatory response, on par with that seen by others, 26, 27 and was significantly less challenging experimentally, LPS was used in all subsequent experiments.
Villus microcirculation does not support PMN TEM Given the observed PMN infiltration of the intestinal epithelium in response to Salmonella infection or LPS treatment, we sought to examine the vasculature in detail to determine the extent to which these vessels could support PMN TEM. We first used intravital multiphoton microscopy and epithelial/innate immune cell reporter mice (E-cadherin CFP/LysM-eGFP, such that IECs are blue, PMNs eGFP hi and macrophages eGFP low ) to examine the villi from the side of the intestinal lumen, using experimental setup similar to that previously described. 28, 29 Dextran-Texas Red (70 kDa, co-injected with LPS into the intestinal lumen) and anti-PECAM-1-conjugated to Alexa Fluor® 555 fluorophore (injected i.v.) were used to demarcate lumen/villus boundaries and the vasculature respectively. By opening up the ileal intestine, we were able to visualize villus architecture from the tip down to a depth of~150-200 nm ( Fig. 2a and schematic Fig. 2b ). Each villus was perfused by an extensive vascular network, with vessels (ranging from 5 to 10 µm in diameter) positioned in close proximity to the epithelial lining (from the tip to the base of the villus, 3D reconstruction of crypts, Fig. 2c and zoom in on vasculature, Fig. 2d ).
Real-time luminal imaging of the villus vasculature under control conditions revealed free-flowing PMNs, with velocities greater than 100 µm/s that rarely engaged in interactions with the vessel wall ( Fig. 2e , g). Both Salmonella infection and LPSmediated inflammation induced PMN interactions with the vessel wall to a similar degree (shown for LPS, Fig. 2e ). Under these conditions, a significant portion of the free-flowing PMNs exhibited transient attachments to the vessel wall, lasting between 1 and 5 s (tethering), with translational velocities of 5.3 ± 0.8 µm/s ( Fig. 2f and Supplemental Video 1). PMN firm adhesion (remaining attached to the vessel wall for more than 20 s) was also observed ( Fig. 2g and Supplemental Video 1). However, although PMN adhesion, a well-documented prerequisite step for TEM, [30] [31] [32] was seen, PMN TEM was never observed in villus vasculature (despite extensive imaging analysis of more than 18 fields in 9 mice and imaging times of up to 45 min, which is more than sufficient time for TEM to take place 33, 34 ). In vivo imaging reveals unique neutrophil transendothelial migration. . . DP Sullivan et al.
Vasculature mapping across layers of the small intestine
Having established that villus microcirculation does not support PMN TEM, we then hypothesized that PMNs extravasate from vessels located closer to the crypts. Given the imaging depth limitations of multiphoton and conventional confocal microscopy, we were unable to resolve the intestinal crypts by imaging from the side of the intestinal lumen. Instead, we used spinning disk intravital microscopy to image the tissue from the serosal side ( Fig. 3a) . Imaging from the serosal surface (shown in schematic, Fig. 3b ) revealed three distinct layers of vessels in the intestinal tissue with superficial microvessels in the muscularis (diameter of 5-10 µm, Fig. 3a , left panel), larger vessels in the submucosa (diameter of 10-40 µm, Fig. 3a , middle panel) and smaller microvessels surrounding intestinal crypts (diameter of 5-10 µm, Fig. 3a , right panel). To map the localization of the vascular network in more detail with respect to the intestinal layers, segments of the small intestine from LysM-eGFP mice were harvested, paraformaldehyde (PFA) fixed, permeabilized and fluorescently stained for EC marker PECAM-1 (red) and actin (blue). The 3D reconstruction analysis revealed that the superficial small vessels were localized to serosal/muscularis layers that stained richly for actin ( Fig. 3c ). In contrast, larger vessels were strictly localized to the submucosal layer, reaching the crypts, but not to villi (3D-reconstructed serosal and luminal views, Fig. 3d ). Our 3D reconstruction analysis and fluorescence staining suggest the width of the serosal/muscularis layer to be~40 µm in thickness and submucosal/mucosal layer to be~60 µm ( Fig. 3d ), consistent with previous reports, 35, 36 and summarized in schematic ( Fig. 3b ). Interestingly, when staining with actin we also detected substantial signal~100 µm into the tissue from the serosal surface. The intensely stained, well-bounded 'cylinders' are consistent with the expected location, distribution and morphology of the crypt lumens, and likely represent the staining of actin in crypt epithelial cells ( Fig. 3c, d ). Each crypt was encircled by a network of small vessels that appeared largely sinusoidal in nature. In inflamed tissue, the interstitial space between the crypts and vessels was replete with bright eGFP hi PMNs and dim eGFP low macrophages.
PMN TEM is restricted to the submucosa vessels By imaging from the serosal side, we were able to resolve the precise location of neutrophils in the various layers in high detail relative to the vasculature. Compared to control, there was a substantial increase in the number of PMNs observed outside of the blood vessels in all strata of the LPS-inflamed small intestine ( Fig. 4a ). However, the most striking difference was observed in the submucosa layer, which had an~10-fold increase over the control (compared to 2.5-and 3-fold increase in the inflamed muscularis and crypt layers, respectively, Fig. 4b ).
Because of the relatively high number of PMNs observed in the submucosa, we next sought to determine whether submucosa vessels preferentially support PMN TEM. We performed intravital imaging from the serosal surface on control and LPS-inflamed intact intestines. With this method, we were able to stain and resolve the muscularis, submucosa and the crypt vasculature in live LysM-eGFP mice. PMNs in unstimulated muscularis and crypt vessels were observed free-flowing in the blood stream with velocities ranging between 100 and 150 µm/s, but rarely engaging or interacting with vessel walls. Upon LPS treatment, the number of PMNs observed per field in both muscularis and crypt layers was significantly increased. Under these conditions, >70% of all PMNs were found to transiently interact with the vessel wall (less than 1 s/interaction), but no continued slow rolling was seen. The average translational velocity of PMNs was significantly reduced, likely resulting from increased PMN contact with the vessel walls. Displacement trajectories of representative PMNs and their initial locations for each condition are indicated by a white dashed line and a star, respectively (Fig. 5a , e and quantified in Fig. 5b , c for muscularis, and F,G for crypt vessels). Importantly, in both strata, PMN firm adhesion was substantially increased (Fig. 5d, h) . Despite the observed PMN adhesion, no PMN TEM from these vessels was observed (Supplemental Videos 2 and 3 show PMNs in muscularis and crypt vessels, respectively). As with villus vasculature, at least 9 mice/condition were used in imaging experiments to substantiate this conclusion. This suggests that the larger submucosal vessels upstream CXCL1/CXCL2 and other intrinsic factors drive PMN TEM in the submucosa EC Ca 2+ is a well-known, critical regulator of PMN TEM. 37, 38 We hypothesized that the preferential localization of PMN TEM to the submucosa vessels could be a result of enhanced Ca 2+ responses in those ECs, compared to ECs in the muscularis layer or intestinal villi. To examine this possibility, we performed intravital microscopy on control and LPS-inflamed vessels in mice expressing the Ca 2+ reporter GCaMP in ECs (GCaMP3 flox/flox expression driven by the CAG promoter and restricted to ECs using VE-Cadherin-Cre). In this setup, an increase in the intracellular Ca 2+ is observed directly as corresponding increase in fluorescence intensity. 39 We therefore quantitated the fluorescence intensity in vessels in the indicated strata of inflamed and control intestines. In response to LPS stimulation, increased signal intensity (and thus, increased EC Ca 2+ ) was observed in vessels in the submucosa, muscularis (Fig. 6a, b ) and villus vasculature (not shown). However, the fold change (ratio of signal measured with LPS versus control) was not different between the two layers, suggesting that Ca 2+ response was not the reason for the restricted PMN TEM in submucosal vessels.
Signaling by chemokines is another important element to regulate PMN TEM. 40, 41 We thus sought to test the possibility that expression of several major PMN chemokines, including (C-X-C motif) ligands 1, 2 and 5 (CXCL1, CXCL2 and CXCL5), varies in the different strata. To quantitate this, we used a previously established protocol 42 to serially section control and LPSinflamed intestinal tissue. This allowed us to harvest and pool representative sections from each of the intestinal layers in question (schematic shown in Fig. 6c ). These samples were then processed and analyzed by quantitative reverse transcriptionpolymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) for messenger RNA (mRNA) and protein content, respectively. The quality and purity of the separation of the strata was confirmed by histological analysis (Fig. 6d ) and the differential expression of villus surface (Claudin 4, Klf4), crypt base (Claudin 2 and Klf5) and smooth muscle actin-α markers (Fig. 6e ). Transcription (Fig. 6f ) and protein (Fig. 6g ) levels for CXCL1 and CXCL2, but not CXCL5, were found to be elevated in the submucosal/crypt layer when compared to villi, suggesting that localization of PMN TEM to the submucosa vasculature during intestinal inflammation could be due to elevated CXCL1/CXCL2 levels.
Both CXCL1 and CXCL2 have been previously shown to have high-affinity binding interactions with PMN-expressed CXC chemokine receptor 2 (CXCR2). 43, 44 To confirm the role of CXCL1/CXCL2 and CXCR2 binding interactions in mediating PMN TEM in the submucosa vessels, mice were treated with the function-blocking anti-CXCR2 Ab (100 µg of Ab in 100 µl, intraperitoneal (i.p.) injection) 30 min prior to LPS administration, and then quantified PMN TEM and recruitment to IECs. CXCR2 inhibition significantly reduced PMN TEM (PMNs in the submucosa layer, Fig. 6h ) and reduced by~70% the LPS-induced PMN infiltration of IECs (Fig. 6i ), confirming the role of PMN receptor/ ligand interactions in TEM.
Finally, we asked whether higher levels of CXCL1 and CXCL2 are sufficient to drive localized PMN TEM. In these experiments, CXCL1 or CXCL2 were administered into the lumen of ligated intestinal loops, 26, 45 to experimentally alter their tissue distribution in such way that the highest concentration of chemokines is now adjacent to the villus circulation. We then monitored PMN TEM and infiltration of IECs using intravital microscopy and parallel flow cytometry analyses. Although both chemokines induced PMN recruitment to the IEC layer ( Fig. 6j) , TEM was still restricted to the submucosa vasculature (Fig. 6k , shown for CXCL1), as was observed with LPS.
These findings suggest that although CXCL1 and CXCL2 can drive PMN TEM, other yet undefined intrinsic differences in vascular ECs or the immediate microenvironment within the intestinal strata also regulate PMN TEM in inflamed intestines.
DISCUSSION
In the presence of inflammatory cues, PMNs are rapidly mobilized from the vasculature to surrounding tissue. Although PMN infiltration of the intestinal mucosa and the luminal space is a prominent feature of IBD and enteropathogenic infections, 2,22 to our knowledge, only one prior study attempted to study PMN recruitment in inflamed intestines by using live imaging approaches. 27 This work determined the extracellular signalregulated kinase activity to be crucial in PMN trafficking across intestinal tissue. The stratification of the intestinal wall has long been known to be important for the overall function of the organ. Here we sought to investigate whether the various strata also respond differently during inflammation, specifically, to determine whether PMN TEM preferentially occurs in villus, submucosa, crypt or the muscularis layer.
Vasculature mapping in the intestinal layers by 3D confocal immunofluorescence microscopy revealed several distinct regions. The villi were (almost exclusively) comprised of an extensive network of small (5-10 µm) vessels extending from each villus tip to its base. Each crypt base was encircled by a single vessel (5-10 µm in diameter). Just below this is the submucosal layer, which contained larger post-capillary venules (10-40 µm in diameter) fed by the crypt vessels. The larger submucosal venules also feed the relatively small (5-10 µm) vessels of the outermost muscularis layer.
Real-time and time-lapse intravital imaging of the luminal surface (villi) in inflamed intestines revealed that despite the proximity to the intestinal epithelium, villus microvessels do not support PMN TEM. These findings are intriguing, as extravasation out of these vessels would constitute the shortest route for PMN While PMN interstitial migration has not been examined in great detail, it has been suggested that this process is regulated by collagen density and the release of metalloproteinases. 46 It can be further constrained by the extracellular matrix (ECM) structure and dependent upon actin-dependent shape change and 'squeezing' ability of migrating cells. 47 Thus, PMN interstitial migration in inflamed intestinal mucosa may serve as an additional regulatory and limiting step for PMN influx into the intestinal tissue. Moreover, we have recently shown that actin-dependent PMN polarization leads to release of microvesicles containing effector proteins, including matrix metalloproteinases 26 and chemokines, 48 that can alter expression of key ECM proteins and facilitate recruitment of other immune cells. Ameboid migration of PMNs in 3D matrices and in vivo settings may further result in PMN degranulation 49, 50 and changes in their transcriptional profile, 51, 52 thus altering their functions upon arrival at the epithelial layers or the intestinal lumen. Indeed, emerging evidence demonstrates increased PMN plasticity, life span and phenotypic heterogeneity in inflamed tissue, 53, 54 which may explain their roles in both promoting tissue injury and facilitating resolution of inflammation.
Importantly, since PMNs can extravasate from small capillaries, as has been observed in the lung, 19, 20 our findings that PMN TEM was restricted to submucosal post-capillary venules suggest that blood vessels or the microenvironment in the intestinal layers may have different molecular or biophysical properties. Although the total Ca 2+ response by ECs in the different strata was not different, we found elevated mRNA and protein levels of key PMN chemoattractants (CXCL1 and CXCL2) in the submucosa layer. Both CXCL1 and CXCL2 have known function in PMN recruitment; however, our work is the first to show their differential expression in the intestinal layers. Intriguingly, our findings suggest that although these chemokines contribute to PMN TEM in the submucosa, other crucial intrinsic differences in endothelial cells and the submucosa microenvironment also contribute to this process. We found that Ab-mediated inhibition of CXCR2 (a high-affinity receptor for both CXCL1 and CXCL2) resulted in significant reduction in PMN TEM; however, shifting the gradient of these chemokines (by luminal administration) from the submucosa to villus circulation was not sufficient to induce PMN TEM in these vessels.
As we further consider the physiological importance of restricted PMN TEM to the submucosa layer, it is tempting to speculate that the proximity of these vessels to several important immunological niches, including the crypt base, is not coincidental. PMNs that exit the submucosa blood vessels in these regions will likely encounter secretory cells, including Paneth and Goblet cells, intestinal stem cells and other resident interstitial cells. 55 How PMNs may regulate tissue homeostasis through crosstalk with these local cells merits further investigation. It is also important to consider whether the observed extravasation patterns are unique to PMNs or also true for other cells that participate in gut immune responses, including monocytes, macrophages and T/B lymphocytes.
In summary, although PMN infiltration of the intestinal tissue is a well-known feature of gastrointestinal inflammation, how PMNs traffic across blood vessels and how they are recruited to inflamed epithelium are not known. Our findings define a distinct pattern of PMN recruitment in inflamed intestines and introduce submucosarestricted PMN TEM followed by interstitial migration as a new regulatory step in PMN trafficking. These unique patterns in the intestines provide targeting opportunities to limit PMN-mediated tissue injury in inflammatory disorders of the gastrointestinal tract.
MATERIALS AND METHODS
Animals
The following mouse strains aged 10-14 weeks were used in experimental protocols: C57BL6J mice (Jackson Laboratories), Ecadherin-mCFP mice (B6.129P2(Cg)-Cdh1tm1Cle, Jackson Laboratories) crossed with LysM-eGFP (Lyz2tm1.1Graf, gift from Dr. Perlman, Northwestern University) and bred to homozygosity, and VE-Cadherin (Cadherin5)-cre R26R mice 56 crossed with GCaMP3 fl/ fl mice (a gift from Gangjian Qin, Northwestern University 57 ) and bred to homozygosity. All mice were maintained under specific pathogen-free conditions at Northwestern University, Feinberg School of Medicine animal facilities. At the end of all experimental procedures animals were killed via rapid cervical dislocation. All protocols involving mice were reviewed and approved by the Institutional Animal Care and Use Committee at Northwestern University (PHS assurance number A328301).
Antibodies and reagents
Function-blocking CD11b (M1/70) and CXCR2 (242216) monoclonal antibodies were from eBioscience (San Diego, CA). An anti-Ly-6G and anti-CD11b conjugated to Alexa Fluor® 488 were from Tonbo Bosciences (San Diego, CA). Non-blocking anti-PECAM-1 antibody (clone 390) was purchased from EMD Millipore (Burlington, MA) and conjugated to DyLight®-550 using an antibody labeling kit from Thermo Fisher (Waltham, MA) according to the manufacture's instructions. PMN chemoattractants CXCL1 (KC) and CXCL2 (MIP2) were from Peprotec (Rocky Hill, NJ). , excised loops were reinserted into the peritoneal cavity for 1-2 h of incubation period. 26, 45 Where indicated, functionblocking anti-CXCR2 antibody (100 μg in 100 μl) was administered i.p. 40 min prior to LPS administration, and anti-CD11b or anti-ICAM-1 Abs (50 μg/ml) were administered via i.v. injection prior to the induction of inflammation.
Intravital imaging Animal setup. Subsequent to induction of inflammation (described above), mice were anesthetized, and a small vertical incision was made to expose small intestinal segments. Without further perturbing the tissue, mice were placed on a heated platform (37°C) and control or inflamed intestinal segments were secured onto a custom-made chamber that was developed and elegantly described in McDole et al., 28 with minor modifications, as detailed below. This setup allows imaging with minimal tissue manipulation. For imaging experiments, a non-blocking anti-PECAM-1 Ab conjugated to DyLight®-550 was administered i.v. (retro-orbital) 30 min prior to imaging to visualize blood vessels.
For serosal imaging, a segment of the small intestine was secured by Vetbond tissue adhesive (3M) between two glass coverslips, one attached to the bottom of the upper chamber plate, located over the incision in the mouse's abdomen, and second a smaller one placed under the intestinal segment and reinserted into the peritoneal cavity. Securing the tissue in such way was sufficient in most cases to overcome peristaltic movement of the small intestine without additional treatments. The imaging chamber was heated and maintained at 37°C and tissue was hydrated by the addition of a small amount of phenol red-free RPMI-1640 at 37°C as needed.
In vivo imaging reveals unique neutrophil transendothelial migration. . . DP Sullivan et al.
For imaging from the luminal surface (villi) an additional incision was made along the dorsal side of the intestinal segment to expose the epithelium lining the intestinal lumen. Care was taken to avoid large blood vessels. The intestine was then washed several times to remove fecal material and mucus from luminal surface and bathed in phenol red-free RPMI-1640 at 37°C. In select experiments, the intestinal lumen was outlined by an intraluminal injection of Dextran-Texas Red MW 70 kDa (10 μg/ml, 20 min prior to imaging). Molecular weight (MW) 70 kDa dextran was used as lower MW dextrans (i.e., 10 kDa or 40 kDa) leak into the interstitium upon induction of inflammation and alteration in the epithelial integrity. 60 All imaging experiments were performed by using either multiphoton or spinning disk confocal microscopy.
Multiphoton imaging. Where indicated, the Nikon A1R-MP upright multiphoton microscope was used for analysis of PMN rolling/adhesion interactions at 30 fps acquisition speed with frame averaging for clarity (×2), and the x-y dimensions of the scan area set at 512 × 512 μm. The microscope was equipped with a Coherent (Santa Clara, CA) tunable titanium-sapphire Chameleon laser system tuned to: 830 nm for the CFP/GFP analysis, 900 nm to visualize Texas Red and 900 nm for Alexa Fluor® 647. For Zstacks of live or fixed tissue, images were acquired sequentially to 80 z-steps (2.0 μm each). Time-lapse imaging was performed at 10 fpm.
Spinning disk confocal imaging. The UltraVIEW VoX imaging system was built on an Olympus BX-51WI Fixed Stage illuminator and equipped with a Yokogawa CSU-X1-A1 spinning disk, a Hamamatsu EMCCD C9100-50 camera and a Modular Laser System with solid state diode lasers with DPPS modules for 488, 561, and 640 nm and the appropriate filters (all assembled by Perkin Elmer, Naperville, IL). Synchronization was managed by a Prosync 2 Syncronization Controller. Z-axis movement and objective positioning was controlled by Piezoelectric MIPOS100 System (Piezoystem Jena, Germany). Images were collected using a 20× water-immersion objective (1.00 numerical aperture). Volocity® software (Perkin Elmer) was used to drive the microscopy and acquire images, which were then analyzed using ImageJ. LysM-eGFP is a well-accepted model for studying PMN trafficking. However, because LysM-eGFP is also expressed by tissue macrophages and monocytes, control experiments were performed with additional labeling of Ly6G (i.v.) to specifically identify PMNs. As expected in an acute inflammatory setting, where PMNs are the first responders, the majority (>90%) of cells in the tissue were PMNs ( Supplementary Fig 1A) . Rare (<5%), LysM-eGFP-positive, Ly6G-negative monocyte/inflammatory macrophages were seen ( Supplementary Fig 1B) . Finally, as shown in Supplementary Fig 1C, eGFP hi tissue PMNs could be clearly distinguished from eGFP low tissue macrophages (by both morphology and GFP intensity, such that monocyte/macrophage signal did not interfere with tissue PMN analyses). Data analysis was performed using ImageJ and Imaris software.
For assessment of EC Ca 2+ responses, EC-specific Ca 2+ reporter mice (VE-Cadherin-cre GCaMP) were used in serosal imaging experiments and imaged using the spinning disk microscope. Fluorescence intensity as an indicator of intracellular Ca 2+ level was quantified in separate experiments with and without LPS stimulation (administered intraluminally into ligated intestinal loops for 1 h).
Analyses of PMN-EC interactions. Cell flux was defined as the number of cells that were visualized in the field of view, per 30 s acquisition time. Free-flowing cells were defined as cells recorded passing through a blood vessel without interacting with the vessel wall. Rolling cells were defined as cells that have remained in continued contact with the vessel wall for greater than 5 s, otherwise cells were defined as tethered. 61 Adherent cells were defined as cells that remained attached to the vessel wall for >20 s.
Immunofluorescence labeling
Cryosections (8 μm width) of O.C.T. (optimal cutting temperature)-frozen intestinal tissue were ethanol fixed, blocked with 5% bovine serum albumin in PBS and incubated with the relevant primary Ab (10 µg/ml, overnight at 4 o C) either directly conjugated or followed by an appropriate fluorescently labeled secondary antibody (1 h at room temperature). Alternatively, whole mount tissue staining was performed by isolating a small segment of small intestine, pinning it flat onto a silicon-coated Petri-dish and immunostaining as above. All images were captured using a Nikon A1R+ confocal microscope with 60× oil objective.
Flow cytometry
Following the relevant treatment, intestinal loops were longitudinally opened. The epithelium and the PMNs that were associated with the epithelial layer (IEC-associated) were dissociated from the rest of the tissue by fragmentation and shaking in 2 mM dithiothreitol (DTT) and 5 mM EDTA in HBSS+ solution (3-5 × 10 min shakes, until no more epithelial cells were visible in the solution as previously described 23, 24 ). Only a small number of macrophages (<3% of all CD45 + immune cell), which typically reside within the LP, 24 were detected in this fraction, suggesting minimal contamination by LP immune cells (not shown). Where specified, PMNs were further extracted from the LP of control and inflamed intestinal segments using a collagenase-mediated tissue digestion as previously described, 25 which separates the LP from the underlying muscularis layer. The number of CD45 + CD11b + Ly6G + PMNs in each fraction was quantified using BD FACS CANTO II and FlowJo software.
Separation of intestinal layers
Intestinal layers were separated as previously described. 42 Briefly, a segment of a small intestine (~0.5 × 1 cm) was longitudinally opened, laid flat between two metal plates and fixed in O.C.T. Intestinal tissue was then sectioned en face along the long axis with section width set to 10 μm. Five sections were recovered for each layer: luminal surface (villi), submucosa (submucosa/crypts) and serosal surface (muscularis). Three transitional sections between the layers were discarded. Sections for each layer were pooled and processed for mRNA and protein analysis. Separation of intestinal layers was confirmed visually using light microscopy, by hematoxylin and eosin (H&E) staining and by expression of specific markers. ELISA CXCL1 and CXCL2 were quantitated from sectioned intestinal layers using standard sandwich ELISA methods. Briefly, tissue sections were lysed in Dulbecco's PBS supplemented with 1.0% Nonidet P-40, 0.1% sodium dodecyl sulfate, 1× protease inhibitor cocktail and 0.5 mM phenylmethylsulfonyl fluoride. Samples were homogenized by 20 passes through a 21 G needle and cleared of insoluble material by centrifugation at 18,000 × g at 4°C for 15 min. Cleared homogenate was tested for the abundance of CXCL1 and CXCL2 using sandwich ELISA kits from LifeSpan BioSciences, Inc. (LS-F31327 and LS-F31334 respectively). Samples were compared to standard curves that were included in each assay and normalized to protein concentrations determined using a standard micro BCA assay (Thermo Fisher). No cross interference between CXCL1 and CXCL2 was detected, suggesting the reagents were highly specific for their intended targets. Also, the effect of small amounts of O.C.T. was confirmed to not interfere with both ELISAs and the micro BCA protein determination.
